Karyopharm Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).
CEORichard A. Paulson
CEORichard A. Paulson
Employees325
Employees325
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded2008
Founded2008
Employees325
Employees325
KPTI Key Statistics
Market cap125.78M
Market cap125.78M
Price-Earnings ratio-0.82
Price-Earnings ratio-0.82
Dividend yield—
Dividend yield—
Average volume1.30M
Average volume1.30M
High today$1.15
High today$1.15
Low today$1.05
Low today$1.05
Open price$1.06
Open price$1.06
Volume1.55M
Volume1.55M
52 Week high$3.87
52 Week high$3.87
52 Week low$0.6174
52 Week low$0.6174
KPTI News
Simply Wall St 4d
Benign Growth For Karyopharm Therapeutics Inc. Underpins Stock's 28% Plummet - Simply Wall StKaryopharm Therapeutics Inc. ( ) shares have retraced a considerable 28% in the last month, reversing a fair amount of their solid recent performance. For any l...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%